AbCellera Biologics Inc. Common Shares

abcellera biologics inc. common shares (abcl) - Quantcha

Check out this and other great ABCELLERA BIOLOGICS INC. COMMON SHARES (ABCL) stock option trades in the range $2.04-$4.22 on January 17, 2025 on Quantcha.

AbCellera Biologics Common Stock Dividends Paid 2019-2024

AbCellera Biologics Inc. is a technology company which searches, decodes and analyzes natural immune systems to find antibodies that its partners can develop ...

ABCL Insider Trading Activity - AbCellera Biologics Inc. - Sec Form 4

Insider Trading Transactions for AbCellera Biologics Inc. Common stock purchase or sale: Reported DateTime, Company Symbol, Insider Relationship, Total ...

AbCellera Announces Closing of Initial Public Offering and Exercise ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera Biologics Inc. ... All of the common shares were offered by AbCellera. The gross proceeds ...

AbCellera Reports Full Year 2020 Business Results

AbCellera Biologics Inc. ; Condensed Consolidated Statement of Operations ; (Expressed in thousands of U.S. dollars except share and per share ...

Amendment: SEC Form SC 13G/A filed by AbCellera Biologics Inc.

Amendment: SEC Form SC 13G/A filed by AbCellera Biologics Inc. ; NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH · 7. SOLE ...

ABCELLERA BIOLOGICS INC. - cloudfront.net

... company, non-cash stock-based compensation in line with ... Issuance of common shares pursuant to exercise of stock options and other.

AbCellera: Home

We are Breaking barriers to develop better antibody medicines for patients. Play Pause We partner with Regeneron Lilly Moderna Gilead Novartis Abdera Denali ...

Thermopylae Holdings Ltd. Acquires 283,516 Common Shares of ...

Following this transaction, Thermopylae Holdings Ltd. directly owns 56,086,009 common shares of AbCellera Biologics. The price range for these ...

$ABCL AbCellera Biologics Q2 2024 Earnings Conference Call

08/06/2024 Q&A: 11:48 AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies ...

AbCellera Biologics Inc.

... share attributable to common shareholders is the same. The Company excluded 2,974,052 and 50,844,425 potential common shares for the three ...

AbCellera Biologics Inc. (ABCL) Prices 24.150M Share IPO at $20/Sh

AbCellera Biologics Inc. (NASDAQ: ABCL), a technology company that aims to become the centralized operating system for next-generation ...

AbCellera Biologics IPO of common shares - Lexpert

The common shares were offered to the public at a price of US$20 per common share for aggregate proceeds to the Company of US$555.5 million, before deducting ...

ABCELLERA BIOLOGICS INC. - cloudfront.net

This Registration Statement on Form S-8 registers 14,541,248 additional Common Shares under the 2020 Share Option and Incentive Plan (the ...

AbCellera Announces Pricing of Initial Public Offering

(“AbCellera”), a technology company that aims to become the centralized operating system for next-generation antibody discovery, today announced ...

Why AbCellera Biologics Inc's (ABCL) Stock Is Up 6.85% | AAII

AbCellera Biologics Inc is up 6.85% from its previous closing price of $5.11. During the last market session, AbCellera Biologics Inc's stock ...

CEO, President & Chairperson of AbCellera Biologics Carl Hansen ...

While AbCellera Biologics insiders bought shares during the last year, they didn't sell. They paid about US$3.05 on average. These transactions ...

AbCellera Announces Pricing of Initial Public Offering - Business Wire

(“AbCellera”), a technology company that aims to become the centralized operating system for next-generation antibody discovery, today announced ...

AbCellera Reports Q1 2023 Business Results

About AbCellera Biologics Inc. AbCellera is breaking the barriers of ... Common shares: no par value, unlimited authorized shares at December 31,.

Thermopylae Holdings Ltd. buys $740k of AbCellera Biologics shares

(NASDAQ:ABCL) through the purchase of shares valued at approximately $740,000. The acquisition consisted of 283,516 common shares at a weighted- ...